A partnership between JDRF and Janssen Pharmaceuticals seeks ways to intercept the disease before it progresses.
Sejal Saraiya, PharmD
Advertisement
Articles by Sejal Saraiya, PharmD
Advertisement
Latest Updated Articles
- Are Low-Cal Sweeteners at the End of Their Game?
Published: December 4th 2014 | Updated:
- The Use and Implementation of Standardized Treatment Pathways
Published: February 16th 2015 | Updated:
- Innovation and the Role of Alternative Markers of Efficacy
Published: February 16th 2015 | Updated:
- Is It Possible to Prevent or Delay Type 1 Diabetes?
Published: November 15th 2015 | Updated:
- Origins and Evidence Behind New ADA Recommendations for Pediatric A1C
Published: September 19th 2014 | Updated:
- Thyroid Cancer: Increased Incidence or Improved Diagnosis?
Published: September 19th 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells
2
FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years
3
Aggressive Therapy Recommendations Following the STRONG-HF Trials: Stephen J. Green, MD
4
Pricing and Insurance Networks in Outpatient Surgery Markets
5
